Cargando…
Effective immunotherapy against canine visceral leishmaniasis with the FML-vaccine
The potential effect of the fucose mannose ligand (FML)-vaccine on immunotherapy of canine visceral leishmaniasis was assayed on five mongrel dogs experimentally infected with Leishmania donovani and on 21 Leishmania chagasi naturally infected dogs when seropositive to FML but completely asymptomati...
Autores principales: | Borja-Cabrera, Gulnara Patricia, Cruz Mendes, Amanda, Paraguai de Souza, Edilma, Hashimoto Okada, Lilian Y, de A Trivellato, Fernando Antonio, Kawasaki, Jarbas Kiyoshi A, Costa, Andreia Cerqueira, Reis, Alexandre Barbosa, Genaro, Odair, Batista, Leopoldina Maria Melo, Palatnik, Marcos, Palatnik-de-Sousa, Clarisa Beatriz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125925/ https://www.ncbi.nlm.nih.gov/pubmed/15149782 http://dx.doi.org/10.1016/j.vaccine.2003.11.039 |
Ejemplares similares
-
Vaccines for Canine Leishmaniasis
por: Palatnik-de-Sousa, Clarisa B.
Publicado: (2012) -
Resistance to visceral leishmaniasis is severely compromised in mice deficient of bradykinin B2-receptors
por: Nico, Dirlei, et al.
Publicado: (2012) -
One Health: The global challenge of epidemic and endemic leishmaniasis
por: Palatnik-de-Sousa, Clarisa B, et al.
Publicado: (2011) -
Nucleoside hydrolase DNA vaccine against canine visceral leishmaniasis
por: Borja-Cabrera, GP, et al.
Publicado: (2009) -
Leishmania donovani Nucleoside Hydrolase (NH36) Domains Induce T-Cell Cytokine Responses in Human Visceral Leishmaniasis
por: Barbosa Santos, Micheli Luize, et al.
Publicado: (2017)